Zimmer Biomet Holdings (ZBH) Tops Q4 EPS by 5c, Beats on Revenue; Offers FY23 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/5/2026
- Dow claims record closing high, S&P 500 advances; chip selloff weighs on Nasdaq
- Broadcom results, guidance beat on soaring AI chip sales; stock slips after hours
- HSBC stays aggressive on stocks, asks what could turn it bearish
- SpaceX sets IPO price at $135 ahead of roadshow in break with Wall Street norms
- Crypto stocks sink as Bitcoin hits a 4-month low
- Wells Fargo Upgrades Oscar Health Inc (OSCR) to Equal Weight 'on Greater Confidence in Exchange Market Trajectory in 2026'
- LCI Industries names interim CEO as Jason Lippert retires
- Broadcom results, guidance beat on soaring AI chip sales; stock slips after hours
- Dow claims record closing high, S&P 500 advances; chip selloff weighs on Nasdaq
- Morgan Stanley lifts MU and SNDK targets, sees 2-3 years of tight memory supply
Zimmer Biomet Announces Fourth Quarter and Full-Year 2022 Financial Results
February 3, 2023 6:30 AM ESTFourth quarter net sales from continuing operations of $1.825 billion increased 2.7% and 8.3% on a constant currency1 basisFourth quarter diluted loss per share from continuing operations was $0.62; adjusted1 diluted earnings per share from continuing operations were $1.88Full-year net sales from continuing operations of $6.940 billion increased 1.6% and 6.6% on a constant currency1 basisFull-year diluted earnings per share from continuing operations were $1.38; adjusted1 diluted earnings per share from continuing operations were $6.89Company provides full-year 2023 financial guidance
WARSAW, Ind., Feb. 3, 2023 /PRNewswire/ -- Zimmer... More
